Kymera Therapeutics (KYMR) Capital Leases (2019 - 2026)
Kymera Therapeutics (KYMR) reported Capital Leases of $840,000 for Q2 2026, down 62.0% from $2.21 million a year earlier and down 27.0% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Capital Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics posted Capital Leases of $1.46 million, down 34.3% from FY2024.
- Capital Leases has a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- By year, Capital Leases came in at $2.23 million in FY2024 (+71.1%), $1.3 million in FY2023 (+4.4%), $1.25 million in FY2022 (+9.3%) and $1.14 million in FY2021 (+88.7%).
- The Q2 2026 figure ranks as the lowest quarterly Capital Leases since Q3 2023.
- Year over year, Capital Leases has now declined in each of the last three quarters, with growth averaging 38.7% over the last eight quarters.
- The high point for year-over-year Capital Leases in five years was Q3 2024 (growth of 171.2%); the low point was Q2 2026 (a decline of 62.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.15 million (Q1 2026), $1.46 million (Q4 2025) and $1.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Kymera Therapeutics | 10.91 Bn | 8.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 840,000.00 |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 943,000.00 |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 643,000.00 |
| Jun 30, 2023 | 762,000.00 |
| Mar 31, 2023 | 989,000.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 690,000.00 |
| Jun 30, 2022 | 927,000.00 |
| Mar 31, 2022 | 927,000.00 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.35 Mn |
API Access
Kymera Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();